1Van Staa TP, Cooper C, Abenhaim A, et al.. Use of oral corticosteroids and risk of fracture [J]. J Bone Miner Res, 2000,15 : 993. 被引量：1
2Walsh L J, Wong CA, Pringle M, et al.. Use of oral cortieosteriods in the community and the prevention of secondary osteoporosis;a cross sectional study[J]. Br Med J ,1996,313:344. 被引量：1
3Gudbiornsson B, Iuliusson UI, Gudjonsson FV. Prevalence of long term steroid treatment and the prequency of decision making to prevent steroid induced osteoporosis in daily clinical practice [J]. Ann Rheum Dis, 2002,61:32. 被引量：1
4Weinstein RS, Jilka RL, Parfitt AM, et al.. Inhibition of osteoblasts and osteoclast by glucocorticoids: Potential mechanisms of their deleterious effects on bone[J] J Clin Invest, 1998,102:274 被引量：1
5Gohel A, Gronowicz G. Glucocorticoids induce apoptosis in osteoblasts by the regulation of Bcl-2, Box and other cell cycle factors[J]. J Bone Miner Res, 1997,12 (suppl 1) :284. 被引量：1
6Delany AM, Gabbitas BY, Canalis E. Cortisol down-regulates osteoblast alpha 1 (Ⅰ) procollagen mRNA by transcriptional and posttranscriptional mechanisms [J]. J Cell Biochem ,1995,57(3) :488. 被引量：1
7Iacey DL, Timms E, Tan H, et (OPG) ligand in a cytokine that al.. Osteoprotegern regulates osteoclast differentiation and activation[J]. Cell, 1998,93: 165 被引量：1
8Hofbauer LC, Gori F, Riggs BL, et al.. Stimulation of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cell: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis[J]. Endocrinology, 1999,140: 4 382 被引量：1
9Sasak N, Kusano E, Anelo Y, et al.. Glucocorticoid decreases circulating osteoprotegrin (OPG) : possible machanism for glucocorticoid induced osteoporosis[J]. Nephrol Dial Transplant, 2001,16 (3) : 479. 被引量：1
10Dovio A, Sartori ML, Masera RG, et al.. Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin(IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression[J]. Cytokine, 2001,15 ( 1 ) :47 被引量：1
4Laura A, Marta GR, Antonio C. Genetic determinants of bone mass. Horm Res, 1999,51 : 105-123. 被引量：1
5Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med, 1990,150:2545-2548. 被引量：1
6Riggs BL, Nguyen TV, Melton LJ, et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res, 1995,10:77-82. 被引量：1
7Stewart TL, Ralston SH. Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol, 2000,166 : 235-245. 被引量：1
8Canalis E. Mechanism of glucocorticoid action in bone: implication to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab,1996,81 : 3441-3447. 被引量：1
9Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997,89:309-319. 被引量：1
10Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun, 1999, 256:449-455. 被引量：1
7Nomura S,Kurate Y,Tomiyama Y. Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids[J].Clinical and Applied Thrombosis/Hemostasis,2010,(06):622-627. 被引量：1
8Yildirim ZK,Buyukavci M,Eren S. Late side effects of highdose steroid therapy on skeletal system in children with idiopathic thrombocytopenic purpura[J].Journal of Pediatric Hematology Oncology,2008,(10):749-753. 被引量：1
